Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

375
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
375

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bayesian sequential learning for prognostication in extremity soft tissue sarcoma (BayeSarc): a retrospective, multicentre cohort study.

The Lancet. Oncology·2026
Same author

The Role of Cemiplimab in Treating Locally Advanced Cutaneous SCC: A UK Single-Centre Experience and the Implications for Surgical Management.

Annals of surgical oncology·2026
Same author

ASO Visual Abstract: The Role of Cemiplimab in Treating Locally Advanced Cutaneous SCC-A UK Single-Centre Experience and the Implications for Surgical Management.

Annals of surgical oncology·2026
Same author

Sentinel lymph node status and oncological outcomes of high-risk and low-risk cutaneous primary melanoma.

World journal of surgical oncology·2026
Same author

ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma.

Annals of surgical oncology·2026
Same author

Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic australasian retroperitoneal sarcoma working group (TARPSWG).

Cancer treatment reviews·2026

Related Experiment Video

Updated: Dec 28, 2025

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.8K

Primary iliocaval leiomyosarcomas: The path beyond surgery.

Chin-Ann J Ong1, Myles J Smith1, Hayden A Snow1

  • 1Sarcoma/Melanoma Unit, The Royal Marsden NHS Foundation Trust, 203 Fulham Rd, Chelsea, London, SW3 6JJ, United Kingdom.

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
|February 19, 2020
PubMed
Summary

Iliocaval leiomyosarcoma (ICLM) is rare. Surgical resection showed a 32.1% 5-year survival rate, with tumor grade and blood loss impacting prognosis. Further research is needed to improve outcomes for this aggressive retroperitoneal sarcoma.

Keywords:
ChemotherapyIliocaval leiomyosarcomaInferior vena cavaRadiotherapyRetroperitoneumSurgery

More Related Videos

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
04:22

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

774
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K

Related Experiment Videos

Last Updated: Dec 28, 2025

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.8K
Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
04:22

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

774
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K

Area of Science:

  • Oncology
  • Surgical Pathology
  • Retroperitoneal Sarcoma Research

Background:

  • Iliocaval leiomyosarcoma (ICLM) is a rare and aggressive retroperitoneal sarcoma.
  • Current treatment lacks consensus on neoadjuvant/adjuvant chemoradiotherapy benefits.
  • This study describes the natural history of chemotherapy-naïve ICLM.

Purpose of the Study:

  • To describe the natural history of ICLM treated in a tertiary cancer center.
  • To explore potential strategies for improving oncological outcomes in ICLM patients.

Main Methods:

  • Prospective database analysis of 30 patients with primary non-metastatic ICLM.
  • Surgical resection performed between 2003 and 2018.
  • Median follow-up of 70.0 months.

Main Results:

  • No 90-day mortality observed.
  • 16.7% local recurrence, 36.7% distant metastasis.
  • Median overall survival of 41.0 months; 5-year overall survival rate was 32.1%.
  • Tumor grade and >600 mL blood loss identified as key prognostic factors.

Conclusions:

  • ICLM management should be centralized in high-volume sarcoma centers.
  • Integration of tumor biology and multi-center trials are crucial for improving outcomes.
  • Further insights into neoadjuvant chemotherapy efficacy are anticipated.